JAKAVI (Ruxolitinib) 20mg x 30 Tablets
JAKAVI (Ruxolitinib) 20mg x 30 Tablets
JAKAVI, containing the active ingredient Ruxolitinib, is a medication used for the treatment of certain conditions related to the immune system and blood disorders. It is primarily indicated for patients with myelofibrosis and polycythemia vera.
Mechanism of Action
Ruxolitinib is a Janus kinase (JAK) inhibitor that works by blocking the activity of specific enzymes involved in the signaling pathways that contribute to the growth and activation of blood cells. This helps to reduce inflammation and control the symptoms associated with these conditions.
Indications
- Myelofibrosis
- Polycythemia Vera
Dosage and Administration
JAKAVI is typically taken orally, with or without food. Dosage is determined by a healthcare professional based on the patient's condition and response to treatment. It is important to follow the prescribed dosage and schedule.
Potential Side Effects
Like all medications, JAKAVI may cause side effects. Common side effects include:
- Increased risk of infections
- Headache
- Dizziness
- Elevated liver enzymes
Patients should report any unusual symptoms or side effects to their healthcare provider promptly.
Precautions
Before starting treatment with JAKAVI, inform your doctor about any existing medical conditions, particularly:
- History of infections
- Liver problems
- Low blood cell counts
Regular monitoring may be required during treatment to ensure safety and effectiveness.
Storage Instructions
Store JAKAVI at room temperature, away from moisture and heat. Keep out of reach of children.
Consultation
Always consult your healthcare provider for personalized advice and before starting any new medication, including JAKAVI.